InvestorsHub Logo
Followers 6
Posts 4111
Boards Moderated 0
Alias Born 12/14/2009

Re: Batermere post# 18444

Monday, 04/17/2017 9:31:48 PM

Monday, April 17, 2017 9:31:48 PM

Post# of 108192
Agreed Batermere. Thanks for posting James.

I find it odd that the Phase 2 trial produced the best ever survival for heavily treated cervical cancer patients yet the market has not repsonded and we are still stick at such a low valuation and lower stock than before the trial was completed. Hopefully validation by way of a pharma deal for AXAL in Europe or US will get us back up to fair value.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News